Mark Cragg

Person

Southampton, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Immunomodulatory antibodies
- Patent number 11,780,929
- Issue date Oct 10, 2023
- Cancer Research Technology Limited
- Aymen Al-Shamkhani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combined use of FcγRIIb (CD32B) and CD20 specific antibodies
- Patent number 11,623,005
- Issue date Apr 11, 2023
- University of Southampton
- Mark Cragg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunomodulatory antibodies
- Patent number 11,001,638
- Issue date May 11, 2021
- Cancer Research Technology Limited
- Aymen Al-Shamkhani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodies
- Patent number 10,525,129
- Issue date Jan 7, 2020
- University of Southampton
- Mark Cragg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
NOVEL COMBINATIONS OF ANTIBODIES AND USES THEREOF
- Publication number 20240092912
- Publication date Mar 21, 2024
- BIOINVENT INTERNATIONAL AB
- Björn Frendéus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINED USE OF FC GAMMA RIIB (CD32B) AND CD20 SPECIFIC ANTIBODIES
- Publication number 20230381310
- Publication date Nov 30, 2023
- UNIVERSITY OF SOUTHAMPTON
- Mark Cragg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY COMBINATIONS FOR TREATMENT OF CANCER IN SPECIFIC PATIENTS
- Publication number 20220259309
- Publication date Aug 18, 2022
- BIOINVENT INTERNATIONAL AB
- Björn FRENDÉUS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOMODULATORY ANTIBODIES
- Publication number 20220213207
- Publication date Jul 7, 2022
- CANCER RESEARCH TECHNOLOGY LIMITED
- Aymen Al-Shamkhani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINED USE OF FC GAMMA RIIB (CD32B) AND CD20 SPECIFIC ANTIBODIES
- Publication number 20210346498
- Publication date Nov 11, 2021
- UNIVERSITY OF SOUTHAMPTON
- Mark Cragg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOMODULATORY ANTIBODIES
- Publication number 20210317222
- Publication date Oct 14, 2021
- CANCER RESEARCH TECHNOLOGY LIMITED
- Aymen Al-Shamkhani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMBINATION AND USE OF ANTIBODIES
- Publication number 20200362036
- Publication date Nov 19, 2020
- BIOINVENT INTERNATIONAL AB
- Björn Frendéus
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINED USE OF FC GAMMA RIIB (CD32B) AND CD20 SPECIFIC ANTIBODIES
- Publication number 20200069798
- Publication date Mar 5, 2020
- UNIVERSITY OF SOUTHAMPTON
- Mark Cragg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOMODULATORY ANTIBODIES
- Publication number 20200017594
- Publication date Jan 16, 2020
- CANCER RESEARCH TECHNOLOGY LIMITED
- Aymen Al-Shamkhani
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CANCER AND B-CELL RELATED DISEASE THERAPY
- Publication number 20190169306
- Publication date Jun 6, 2019
- UNIVERSITY OF SOUTHAMPTON
- Martin John Glennie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOMODULATORY ANTIBODIES
- Publication number 20180327504
- Publication date Nov 15, 2018
- CANCER RESEARCH TECHNOLOGY LIMITED
- Aymen Al-Shamkhani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MEDICAMENTS, USES AND METHODS
- Publication number 20170107293
- Publication date Apr 20, 2017
- BIOINVENT INTERNATIONAL AB
- Björn Frendéus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINED USE OF FC GAMMA RIIB (CD32B) AND CD20 - SPECIFIC ANTIBODIES
- Publication number 20130251706
- Publication date Sep 26, 2013
- UNIVERSITY OF SOUTHAMPTON
- Mark Cragg
- G01 - MEASURING TESTING

Person

Patents Grantslast 30 patents

Immunomodulatory antibodies

Combined use of FcγRIIb (CD32B) and CD20 specific antibodies

Immunomodulatory antibodies

Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodies

Patents Applicationslast 30 patents

NOVEL COMBINATIONS OF ANTIBODIES AND USES THEREOF

COMBINED USE OF FC GAMMA RIIB (CD32B) AND CD20 SPECIFIC ANTIBODIES

ANTIBODY COMBINATIONS FOR TREATMENT OF CANCER IN SPECIFIC PATIENTS

IMMUNOMODULATORY ANTIBODIES

COMBINED USE OF FC GAMMA RIIB (CD32B) AND CD20 SPECIFIC ANTIBODIES

IMMUNOMODULATORY ANTIBODIES

NOVEL COMBINATION AND USE OF ANTIBODIES

COMBINED USE OF FC GAMMA RIIB (CD32B) AND CD20 SPECIFIC ANTIBODIES

IMMUNOMODULATORY ANTIBODIES

CANCER AND B-CELL RELATED DISEASE THERAPY

IMMUNOMODULATORY ANTIBODIES

MEDICAMENTS, USES AND METHODS

COMBINED USE OF FC GAMMA RIIB (CD32B) AND CD20 - SPECIFIC ANTIBODIES